| 2024 |
Vink, R. (2024). Preface. Substance P from Pain to Cancer, xxv-xxvi. DOI |
| 2024 |
Vink, R., & Nimmo, A. (2024). Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury. International Journal of Molecular Sciences, 25(6), 18 pages. DOI Scopus3 WoS2 Europe PMC2 |
| 2024 |
Sorby-Adams, A. J., Marian, O. C., Bilecki, I. M., Elms, L. E., Yassi, N., Hood, R. J., . . . Turner, R. J. (2024). NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke. Journal of Cerebral Blood Flow and Metabolism, 44(10), 1759-1773. DOI Scopus4 WoS1 Europe PMC1 |
| 2024 |
Byard, R. W., & Vink, R. (2024). Does citing early SIDS research skew contemporary conclusions?. Forensic Science, Medicine, and Pathology, 21(2), 981-983. DOI |
| 2024 |
Tiemensma, M., Byard, R. W., Vink, R., Affleck, A. J., Blumbergs, P., & Buckland, M. E. (2024). Chronic traumatic encephalopathy (CTE) in the context of longstanding intimate partner violence. Acta Neuropathologica, 148(1), 1-3. DOI Scopus13 WoS10 Europe PMC10 |
| 2023 |
Byard, R., Tiemensma, M., Buckland, M. E., & Vink, R. (2023). Chronic traumatic encephalopathy (CTE)—features and forensic considerations. Forensic Science Medicine and Pathology, 19(4), 620-624. DOI Scopus13 WoS11 Europe PMC6 |
| 2022 |
Vink, R., & Corrigan, F. (2022). Chronic traumatic encephalopathy: Genes load the gun and repeated concussion pulls the trigger. Neural Regeneration Research, 17(9), 1963-1964. DOI Scopus1 |
| 2022 |
Shaukat, Z., Byard, R. W., Vink, R., Hussain, R., Ricos, M. G., & Dibbens, L. M. (2022). Investigating genetic variants in microRNA regulators of Neurokinin-1 receptor in sudden infant death syndrome. Acta Paediatrica, 112(2), 4 pages. DOI Scopus1 Europe PMC1 |
| 2021 |
Corrigan, F., Cernak, I., McAteer, K., Hellewell, S. C., Rosenfeld, J. V., Turner, R. J., & Vink, R. (2021). NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury. Scientific Reports, 11(1), 1-9. DOI Scopus18 WoS15 Europe PMC19 |
| 2021 |
Byard, R. W., & Vink, R. (2021). Does listing of individual contributions in “Mega-Authorship” papers always follow best practice guidelines?. Forensic Science, Medicine and Pathology, 17(4), 545-546. DOI Scopus6 WoS6 Europe PMC4 |
| 2019 |
Stewart, W., Allinson, K., Al Sarraj, S., Bachmeier, C., Vink, R., & Smith, D. H. (2019). Primum non nocere: a call for balance when reporting on CTE. The lancet neurology, 18(3), 231-233. DOI Scopus59 WoS50 Europe PMC36 |
| 2019 |
Agoston, D. V., Vink, R., Helmy, A., Risling, M., Nelson, D., & Prins, M. (2019). How to translate time: the temporal aspects of rodent and human pathobiological processes in traumatic brain injury. Journal of Neurotrauma, 36(11), 1724-1737. DOI Scopus41 WoS36 Europe PMC36 |
| 2019 |
Sorby-Adams, A. J., Leonard, A., Elms, L. E., Marian, O. C., Hoving, J. W., Yassi, N., . . . Turner, R. J. (2019). Determining the temporal profile of intracranial pressure changes following transient stroke in an ovine model. Frontiers in Neuroscience, 13(00587), 587-1-587-16. DOI Scopus13 WoS13 Europe PMC12 |
| 2019 |
Sorby-Adams, A. J., Leonard, A., Hoving, J. W., Yassi, N., Vink, R., Wells, A. J., & Turner, R. J. (2019). NK1-r antagonist treatment comparable to decompressive craniectomy in reducing intracranial pressure following stroke. Frontiers in Neuroscience, 13(00681), 681-1-681-12. DOI Scopus14 WoS14 Europe PMC12 |
| 2018 |
Sorby-Adams, A., Vink, R., & Turner, R. (2018). Large animal models of stroke and traumatic brain injury as translational tools. American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 315(2), 165-190. DOI Scopus88 WoS83 Europe PMC74 |
| 2018 |
Bright, F., Vink, R., & Byard, R. (2018). Neuropathological Developments in Sudden Infant Death Syndrome. Pediatric and Developmental Pathology, 21(6), 515-521. DOI Scopus18 WoS15 Europe PMC12 |
| 2018 |
Bright, F. M., Vink, R., & Byard, R. W. (2018). The potential role of substance P in brainstem homeostatic control in the pathogenesis of sudden infant death syndrome (SIDS). Neuropeptides, 70, 1-8. DOI Scopus15 WoS8 Europe PMC10 |
| 2018 |
Byard, R., Donkin, J., & Vink, R. (2018). The Forensic Implications of Amphetamine Intoxication in Cases of Inflicted Blunt Craniocerebral Trauma. Journal of Forensic Sciences, 63(1), 151-153. DOI Scopus10 WoS6 Europe PMC4 |
| 2018 |
Vink, R. (2018). Large animal models of traumatic brain injury. Journal of Neuroscience Research, 96(4), 527-535. DOI Scopus121 WoS114 Europe PMC97 |
| 2018 |
Byard, R., Bright, F., & Vink, R. (2018). Why is a prone sleeping position dangerous for certain infants?. Forensic Science, Medicine, and Pathology, 14(1), 114-116. DOI Scopus19 WoS13 Europe PMC8 |
| 2018 |
Bright, F., Byard, R., Vink, R., & Paterson, D. (2018). Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development. Brain research bulletin, 137, 319-328. DOI Scopus13 WoS9 Europe PMC9 |
| 2018 |
Plummer, S., Corrigan, F., Thornton, E., Woenig, J., Vink, R., Cappai, R., & Den Heuvel, C. (2018). The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury. PLoS ONE, 13(1), e0190449-1-e0190449-16. DOI Scopus17 WoS15 Europe PMC12 |
| 2018 |
Vink, R. (2018). Reflections on 35 Years of Journal of Neurotrauma. Journal of Neurotrauma, 35(1), 13-14. DOI |
| 2017 |
Ameliorate, J. L., Ghabriel, M. N., & Vink, R. (2017). Magnesium enhances the beneficial effects of NK1 antagonist administration on blood-brain barrier permeability and motor outcome after traumatic brain injury. Magnesium research, 30(3), 88-97. DOI Scopus12 WoS12 Europe PMC11 |
| 2017 |
Bright, F., Vink, R., Byard, R., Duncan, J., Krous, H., & Paterson, D. (2017). Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex. PloS One, 12(9), e0184958-1-e0184958-14. DOI Scopus27 WoS21 Europe PMC19 |
| 2017 |
Bright, F., Byard, R., Vink, R., & Patersonv, D. (2017). Medullary serotonin neuron abnormalities in an Australian cohort of sudden infant death syndrome. Journal of Neuropathology and Experimental Neurology, 76(10), 864-873. DOI Scopus28 WoS22 Europe PMC21 |
| 2017 |
Vink, R., Gabrielian, L., & Thornton, E. (2017). The role of substance P in secondary pathophysiology after traumatic brain injury. Frontiers in Neurology, 8(304), 304-1-304-8. DOI Scopus56 WoS48 Europe PMC41 |
| 2017 |
Corrigan, F., Arulsamy, A., Collins-Praino, L., Holmes, J., & Vink, R. (2017). Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation. Brain, Behavior, and Immunity, 64(3), 124-139. DOI Scopus41 WoS37 Europe PMC30 |
| 2017 |
Zhou, C., Vink, R., & Byard, R. (2017). Hyperosmolarity Induces Armanni-Ebstein-like Renal Tubular Epithelial Swelling and Cytoplasmic Vacuolization. Journal of Forensic Sciences, 62(1), 229-232. DOI Scopus6 WoS8 Europe PMC8 |
| 2016 |
Katharesan, V., Lewis, M., Vink, R., & Johnson, I. (2016). Disparate changes in plasma and brainstem cytokine levels in adult and ageing rats associated with age-related changes in facial motor neuron number, snout muscle morphology, and exploratory behavior. Frontiers in Neurology, 7(191), 191-1-191-9. DOI Scopus7 WoS7 Europe PMC5 |
| 2016 |
Vink, R. (2016). Magnesium in the CNS: recent advances and developments. Magnesium research, 29(3), 95-101. DOI Scopus39 WoS36 Europe PMC21 |
| 2016 |
Busingye, D., Turner, R., & Vink, R. (2016). Combined magnesium/polyethylene glycol facilitates the neuroprotective effects of magnesium in traumatic brain injury at a reduced magnesium dose. CNS Neuroscience and Therapeutics, 22(10), 854-859. DOI Scopus13 WoS12 Europe PMC8 |
| 2016 |
McAteer, K., Corrigan, F., Thornton, E., Turner, R., & Vink, R. (2016). Short and long term behavioral and pathological changes in a novel rodent model of repetitive mild traumatic brain Injury. PLOS ONE, 11(8), e0160220-1-e0160220-18. DOI Scopus81 WoS81 Europe PMC74 |
| 2016 |
Loughran, S., Al Hossain, M., Bentvelzen, A., Elwood, M., Finnie, J., Horvat, J., . . . Croft, R. (2016). Bioelectromagnetics research within an Australian context: the Australian centre for electromagnetic bioeffects research (ACEBR). International Journal of Environmental Research and Public Health, 13(10), 1-14. DOI Scopus5 WoS5 Europe PMC1 |
| 2016 |
Corrigan, F., Mander, K., Leonard, A., & Vink, R. (2016). Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. Journal of Neuroinflammation, 13(1), 264-1-264-12. DOI Scopus273 WoS255 Europe PMC211 |
| 2016 |
Shultz, S. R., McDonald, S. J., Vonder Haar, C., Meconi, A., Vink, R., van Donkelaar, P., . . . Christie, B. R. (2016). The potential for animal models to provide insight into mild traumatic brain injury: Translational challenges and strategies. Neuroscience and Biobehavioral Reviews, 76(Pt B), 19 pages. DOI Scopus127 WoS127 Europe PMC106 |
| 2016 |
Leonard, A., Vink, R., & Byard, R. (2016). Brain Fluid Content Related to Body Position and Postmortem Interval - An Animal Model. Journal of Forensic Sciences, 61(3), 671-673. DOI Scopus8 WoS4 Europe PMC4 |
| 2016 |
Corrigan, F., Vink, R., & Turner, R. J. (2016). Inflammation in acute CNS injury: a focus on the role of substance P. British Journal of Pharmacology, 173(4), 703-715. DOI Scopus59 WoS50 Europe PMC49 |
| 2015 |
Newcombe, R., Finnie, J., Leonard, A., Manavis, J., Reilly, P., Vink, R., & Blumbergs, P. (2015). Apoptosis in human compressive myelopathy due to metastatic neoplasia. Spine, 40(8), E450-E457. DOI Scopus1 |
| 2015 |
Leonard, A., & Vink, R. (2015). Reducing intrathecal pressure after traumatic spinal cord injury: a potential clinical target to promote tissue survival. Neural Regeneration Research, 10(3), 380-382. DOI Scopus7 WoS6 Europe PMC6 |
| 2015 |
Wells, A., Vink, R., Helps, S., Knox, S., Blumbergs, P., & Turner, R. (2015). Elevated intracranial pressure and cerebral edema following permanent MCA occlusion in an ovine model. PLoS One, 10(6), e0130512-1-e0130512-20. DOI Scopus21 WoS21 Europe PMC20 |
| 2015 |
Thornton, E., & Vink, R. (2015). Substance p and its tachykinin NK1 receptor: a novel neuroprotective target for parkinson’s disease. Neural Regeneration Research, 10(9), 1403-1405. DOI Scopus16 WoS12 Europe PMC11 |
| 2015 |
Leonard, A., Thornton, E., & Vink, R. (2015). The relative contribution of edema and hemorrhage to raised intrathecal pressure following traumatic spinal cord injury. Journal of neurotrauma, 32(6), 397-402. DOI Scopus57 WoS51 Europe PMC43 |
| 2015 |
Court-Kowalski, S., Finnie, J., Manavis, J., Blumbergs, P., Helps, S., & Vink, R. (2015). Effect of long-term (2 years) exposure of mouse brains to global system for mobile communication (GSM) radiofrequency fields on astrocytic immunoreactivity. Bioelectromagnetics, 36(3), 245-250. DOI Scopus11 WoS9 Europe PMC8 |
| 2014 |
Leonard, A., Thornton, E., & Vink, R. (2014). NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury. PLoS One, 9(5), e98364-1-e98364-15. DOI Scopus12 WoS10 Europe PMC8 |
| 2014 |
Leonard, A., Manavis, J., Blumbergs, P., & Vink, R. (2014). Changes in substance P and NK1 receptor immunohistochemistry following human spinal cord injury. Spinal Cord, 52(1), 17-23. DOI Scopus12 WoS12 Europe PMC10 |
| 2014 |
Byard, R. W., & Vink, R. (2014). The law and the laboratory. Forensic Science, Medicine, and Pathology, 10(4), 481-482. DOI Scopus1 WoS1 |
| 2014 |
Mander, K., Harford-Wright, E., Lewis, K., & Vink, R. (2014). Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide substance P and its antagonists as anti-cancer agents. Recent Patents on CNS Drug Discovery, 9(2), 110-121. DOI Scopus9 Europe PMC4 |
| 2014 |
Anderson, R. W. G., Sandoz, B., Dutschke, J. K., Finnie, J. W., Turner, R. J., Blumbergs, P. C., . . . Vink, R. (2014). Biomechanical studies in an ovine model of non-accidental head injury. Journal of Biomechanics, 47(11), 2578-2583. DOI Scopus19 WoS16 Europe PMC15 |
| 2014 |
Harford-Wright, E., Lewis, K., Ghabriel, M., & Vink, R. (2014). Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors. PLoS One, 9(5), e97002-1-e97002-7. DOI Scopus27 WoS22 Europe PMC18 |
| 2014 |
Turner, R., & Vink, R. (2014). NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke. Neuropeptides, 48(5), 267-272. DOI Scopus19 WoS15 Europe PMC14 |
| 2014 |
Giacci, M., Wheeler, L., Lovett, S., Dishington, E., Majda, B., Bartlett, C., . . . Fitzgerald, M. (2014). Differential effects of 670 and 830 nm red near infrared irradiation therapy: a comparative study of optic nerve injury, retinal degeneration, traumatic brain and spinal cord injury. PLoS One, 9(8), e104565-1-e104565-15. DOI Scopus46 WoS40 Europe PMC32 |
| 2014 |
Thornton, E., Hassall, M., Corrigan, F., & Vink, R. (2014). The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model. Parkinsonism and Related Disorders, 20(5), 508-513. DOI Scopus24 WoS23 Europe PMC24 |
| 2014 |
Bates, K., Vink, R., Martins, R., & Harvey, A. (2014). Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain. Neurobiology of Aging, 35(6), 1345-1351. DOI Scopus23 WoS21 Europe PMC19 |
| 2014 |
Harford-Wright, E., Lewis, K., Vink, R., & Ghabriel, M. N. (2014). Evaluating the role of substance P in the growth of brain tumors. Neuroscience, 261, 85-94. DOI Scopus23 WoS20 Europe PMC17 |
| 2014 |
Corrigan, F., Thornton, E., Roisman, L., Leonard, A., Vink, R., Blumbergs, P., . . . Cappai, R. (2014). The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96-110. Journal of Neurochemistry, 128(1), 196-204. DOI Scopus48 WoS46 Europe PMC40 |
| 2013 |
Leonard, A., Thornton, E., & Vink, R. (2013). Substance P as a mediator of neurogenic inflammation after balloon compression induced spinal cord injury. Journal of Neurotrauma, 30(21), 1812-1823. DOI Scopus24 WoS19 Europe PMC21 |
| 2013 |
Gabrielian, L., Helps, S., Thornton, E., Turner, R., Leonard, A., & Vink, R. (2013). Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure. Acta Neurochirurgica Supplement, Brain edema XV, 118, 201-204. DOI Scopus39 Europe PMC34 |
| 2013 |
Leonard, A., & Vink, R. (2013). The effect of an NK1 receptor antagonist on blood spinal cord barrier permeability following balloon compression-induced spinal cord injury. Acta Neurochirurgica Supplement, Brain edema XV, 118, 303-306. DOI Scopus7 Europe PMC4 |
| 2013 |
Lewis, K., Turner, R., & Vink, R. (2013). Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system. International Journal of Inflammation, 2013(578480), 1-16. DOI Scopus25 WoS22 Europe PMC16 |
| 2013 |
Fitzgerald, M., Hodgetts, S., Van Den Heuvel, C., Natoli, R., Hart, N., Valter, K., . . . Dunlop, S. (2013). Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders. Reviews in the Neurosciences, 24(2), 205-226. DOI Scopus74 WoS62 Europe PMC54 |
| 2013 |
Harford-Wright, E., Lewis, K., & Vink, R. (2013). The potential for substance P antagonists as anti-cancer agents in brain tumours. Recent Patents on CNS Drug Discovery, 8(1), 13-23. DOI Scopus9 Europe PMC7 |
| 2013 |
Lewis, K., Harford-Wright, E., Vink, R., & Ghabriel, M. (2013). NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer. Anti-Cancer Drugs, 24(4), 344-354. DOI Scopus16 WoS14 Europe PMC13 |
| 2013 |
Lewis, K., Harford-Wright, E., Vink, R., & Ghabriel, M. (2013). Characterisation of Walker 256 breast carinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours. Cancer Cell International, 13(5), 1-12. DOI Scopus13 WoS14 Europe PMC14 |
| 2013 |
Finnie, J., Blumbergs, P., Manavis, J., & Vink, R. (2013). Pattern of cerebrospinal immediate early gene c-fos expression in an ovine model of non-accidental head injury. Journal of Clinical Neuroscience, 20(12), 1759-1761. DOI Scopus2 WoS9 Europe PMC9 |
| 2013 |
Byard, R., & Vink, R. (2013). Speed of development of cerebral swelling following blunt cranial trauma. Journal of Forensic and Legal Medicine, 20(6), 598-600. DOI Scopus8 WoS8 Europe PMC7 |
| 2013 |
Lewis, K., Harford-Wright, E., Vink, R., Nimmo, A., & Ghabriel, M. (2013). Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion. Clinical & Experimental Metastasis, 30(1), 1-12. DOI Scopus26 WoS20 Europe PMC22 |
| 2013 |
Turner, R., & Vink, R. (2013). The role of substance P in ischaemic brain injury. Brain Sciences, 3(1), 123-142. DOI Scopus19 WoS17 Europe PMC14 |
| 2013 |
Finnie, J. W., Blumbergs, P. C., Manavis, J., & Vink, R. (2013). Pattern of cerebrospinal immediate early gene c-fos expression in an ovine model of non-accidental head injury. Journal of Clinical Neuroscience, 20(12), 1759-1761. DOI Scopus9 |
| 2012 |
Helps, S., Thornton, E., Kleinig, T., Manavis, J., & Vink, R. (2012). Automatic nonsubjective estimation of antigen content visualized by immunohistochemistry using color deconvolution. Applied Immunohistochemistry and Molecular Morphology, 20(1), 82-90. DOI Scopus62 WoS59 Europe PMC47 |
| 2012 |
Byard, R., Elliott, J., & Vink, R. (2012). Infant gender, shared sleeping and sudden death. Journal of Paediatrics and Child Health, 48(6), 517-519. DOI Scopus27 WoS18 Europe PMC12 |
| 2012 |
Corrigan, F., Vink, R., Blumbergs, P., Masters, C., Cappai, R., & Van Den Heuvel, C. (2012). sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. Journal of Neurochemistry, 122(1), 208-220. DOI Scopus70 WoS67 Europe PMC57 |
| 2012 |
Corrigan, F., Leonard, A., Ghabriel, M., Van Den Heuvel, C., & Vink, R. (2012). A Substance P Antagonist Improves Outcome in Female Sprague Dawley Rats Following Diffuse Traumatic Brain Injury. CNS Neuroscience & Therapeutics, 18(6), 513-515. DOI Scopus25 WoS22 Europe PMC19 |
| 2012 |
Carthew, H., Ziebell, J., & Vink, R. (2012). Substance P-induced changes in cell genesis following diffuse traumatic brain injury. Neuroscience, 214, 78-83. DOI Scopus29 WoS26 Europe PMC22 |
| 2012 |
Corrigan, F., Vink, R., Blumbergs, P., Masters, C., Cappai, R., & Van Den Heuvel, C. (2012). Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury. Brain Research, 1451, 87-99. DOI Scopus37 WoS36 Europe PMC35 |
| 2012 |
Barry, C., Turner, R., Corrigan, F., & Vink, R. (2012). New therapeutic approaches to subarachnoid hemorrhage. Expert Opinion on Investigational Drugs, 21(6), 845-859. DOI Scopus21 WoS14 Europe PMC14 |
| 2012 |
Corrigan, F., Vink, R., Blumbergs, P., Masters, C., Cappai, R., & Van Den Heuvel, C. (2012). Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice. Neuroscience Letters, 515(1), 50-54. DOI Scopus17 WoS17 Europe PMC15 |
| 2012 |
Thornton, E., & Vink, R. (2012). Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's Disease. PLoS One, 7(4), 1-8. DOI Scopus82 WoS85 Europe PMC66 |
| 2012 |
Turner, R., & Vink, R. (2012). Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats. Neuroscience, 220, 1-10. DOI Scopus29 WoS27 Europe PMC23 |
| 2012 |
Sandoz, B., Dutschke, J., Liu, Q., Manavis, J., Finnie, J., Vink, R., & Anderson, R. (2012). In vivo biomechanical response of ovine heads to shaken baby syndrome events. Computer Methods in Biomechanics and Biomedical Engineering, 15(S1), 293-294. DOI Scopus8 Europe PMC5 |
| 2012 |
Leong, W., Henshall, T., Arthur, A., Kremer, K., Lewis, M., Helps, S., . . . Koblar, S. (2012). Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Translational Medicine, 1(3), 177-187. DOI Scopus154 WoS135 Europe PMC124 |
| 2012 |
Elliott, J., Vink, R., Jensen, L., & Byard, R. (2012). Brain weight-body weight ratio in sudden infant death syndrome revisited. Medicine Science and the Law, 52(4), 207-209. DOI Scopus10 WoS10 Europe PMC10 |
| 2012 |
Barry, C., Van Den Heuvel, C., Helps, S., & Vink, R. (2012). Cushing's mechanism maintains cerebral perfusion pressure in experimental subarachnoid haemorrhage. Neuroscience Letters, 529(1), 92-96. DOI Scopus2 WoS2 Europe PMC2 |
| 2012 |
Lewis, K., Harford-Wright, E., Vink, R., & Ghabriel, M. (2012). Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours. Journal of Neuroimmunology, 250(1-2), 59-65. DOI Scopus8 WoS5 Europe PMC6 |
| 2012 |
Wells, A., Vink, R., Blumbergs, P., Brophy, B., Helps, S., Knox, S., & Turner, R. (2012). A surgical model of permanent and transient middle cerebral artery stroke in the sheep. PLoS One, 7(7), 1-9. DOI Scopus50 WoS50 Europe PMC42 |
| 2012 |
Finnie, J., Blumbergs, P., Manavis, J., Turner, R., Helps, S., Vink, R., . . . Anderson, R. (2012). Neuropathological changes in a lamb model of non-accidental head injury (the shaken baby syndrome). Journal of Clinical Neuroscience, 19(8), 1159-1164. DOI Scopus70 WoS58 Europe PMC46 |
| 2012 |
Vink, R., & Byard, R. (2012). Alcohol intoxication may exacerbate the effects of blunt cranial trauma through changes in brain free magnesium levels. Journal of Forensic Sciences, 57(4), 979-982. DOI Scopus8 WoS6 Europe PMC3 |
| 2012 |
Byard, R., Gabrielian, L., Helps, S., Thornton, E., & Vink, R. (2012). Further Investigations into the speed of cerebral swelling following blunt cranial trauma. Journal of Forensic Sciences, 57(4), 973-975. DOI Scopus24 WoS22 Europe PMC17 |
| 2011 |
Wheaton, P., Mathias, J., & Vink, R. (2011). Impact of pharmacological treatments on outcome in adult rodents after traumatic brain injury: a meta-analysis. Journal of Psychopharmacology, 25(12), 1581-1599. DOI Scopus24 WoS19 Europe PMC18 |
| 2011 |
Gabrielian, L., Willshire, L., Helps, S., Van Den Heuvel, C., Mathias, J., & Vink, R. (2011). Intracranial pressure changes following traumatic brain injury in rats: Lack of significant change in the absence of mass lesions or hypoxia. Journal of Neurotrauma, 28(10), 2103-2111. DOI Scopus25 WoS24 Europe PMC23 |
| 2011 |
Wheaton, P., Mathias, J., & Vink, R. (2011). Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: A meta-analysis. Journal of Clinical Psychopharmacology, 31(6), 745-757. DOI Scopus70 WoS55 Europe PMC48 |
| 2011 |
Harford-Wright, E., Lewis, K., & Vink, R. (2011). Towards drug discovery for brain tumours: interaction of kinins and tumours at the blood brain barrier interface. Recent Patents on CNS Drug Discovery, 6(1), 31-40. DOI Scopus19 Europe PMC6 |
| 2011 |
Corrigan, F., Pham, C., Vink, R., Blumbergs, P., Masters, C., Van Den Heuvel, C., & Cappai, R. (2011). The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Research, 1378, 137-143. DOI Scopus66 WoS66 Europe PMC57 |
| 2011 |
Barry, C., Helps, S., Van Den Heuvel, C., & Vink, R. (2011). Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage. Brain Research, 1389, 143-151. DOI Scopus25 WoS23 Europe PMC22 |
| 2011 |
Turner, R., Helps, S., Thornton, E., & Vink, R. (2011). A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke. Brain Research, 1393, 84-90. DOI Scopus56 WoS49 Europe PMC48 |
| 2011 |
Donkin, J., Cernak, I., Blumbergs, P., & Vink, R. (2011). A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. Journal of Neurotrauma, 28(2), 217-224. DOI Scopus55 WoS52 Europe PMC48 |
| 2011 |
Corrigan, F., Ziebell, J., & Vink, R. (2011). Models of rodent cortical traumatic brain injury. Neuromethods, 62, 193-209. DOI Scopus3 |
| 2010 |
Thornton, E., Ziebell, J., Leonard, A., & Vink, R. (2010). Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury. Molecules, 15(9), 6598-6618. DOI Scopus38 WoS39 Europe PMC36 |
| 2010 |
Harford-Wright, E., Thornton, E., & Vink, R. (2010). Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury. Neuroscience Letters, 481(1), 26-29. DOI Scopus41 WoS37 Europe PMC34 |
| 2010 |
Thornton, E., Tran, T., & Vink, R. (2010). A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death. Neuroscience Letters, 481(1), 64-67. DOI Scopus24 WoS20 Europe PMC18 |
| 2010 |
Zacest, A., Vink, R., Manavis, J., Sarvestani, G., & Blumbergs, P. (2010). Substance P immunoreactivity increases following human traumatic brain injury. Acta Neurochirurgica. Supplementum, 106(Supplement 106), 211-216. DOI Scopus25 WoS34 Europe PMC31 |
| 2010 |
Vink, R., & Bullock, R. (2010). Traumatic brain injury: Therapeutic challenges and new directions. Neurotherapeutics, 7(1), 1-2. DOI Scopus31 WoS36 Europe PMC32 |
| 2010 |
Vink, R., & Van Den Heuvel, C. (2010). Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics, 7(1), 74-80. DOI Scopus49 WoS41 Europe PMC35 |
| 2010 |
Donkin, J., & Vink, R. (2010). Mechanisms of cerebral edema in traumatic brain injury: Therapeutic developments. Current Opinion in Neurology, 23(3), 293-299. DOI Scopus307 WoS279 Europe PMC250 |
| 2010 |
Cook, N., Vink, R., Helps, S., Manavis, J., & Van Den Heuvel, C. (2010). Transient receptor potential melastatin 2 expression is increased following experimental traumatic brain injury in rats. Journal of Molecular Neuroscience, 42(2), 192-199. DOI Scopus37 WoS33 Europe PMC26 |
| 2010 |
Cook, N., Kleinig, T., Van Den Heuvel, C., & Vink, R. (2010). Reference genes for normalising gene expression data in collagenase-induced rat intracerebral haemorrhage. BMC Molecular Biology, 11(7), 1-11. DOI Scopus19 WoS17 Europe PMC19 |
| 2010 |
Ghabriel, M., Zdziarski, I., Leigh, C., & Vink, R. (2010). Changes in the blood-CSF barrier in experimental traumatic brain injury. Proceedings of Brain Edema XIV, 106(Supplement 106), 239-246. DOI Scopus9 WoS9 Europe PMC9 |
| 2010 |
Cernak, I., Chang, T., Ahmed, F., Cruz, M., Vink, R., Stoica, B., & Faden, A. (2010). Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Developmental Neuroscience, 32(5-6), 442-453. DOI Scopus33 WoS28 Europe PMC29 |
| 2010 |
Thornton, E., Hassall, M., & Vink, R. (2010). Substance P antagonists reduce onset of experimental L-DOPA induced dyskinesia. Movement Disorders, 25(S2), 211-212. DOI |
| 2009 |
Wheaton, P., Mathias, J. L., & Vink, R. (2009). Impact of early pharmacological treatment on cognitive and behavioral outcome after traumatic brain injury in adults : a meta-analysis. Journal of clinical psychopharmacology, 29(5), 468-477. DOI |
| 2009 |
Cook, N., Van Den Heuvel, C., & Vink, R. (2009). Are the transient receptor potential melastatin (TRPM) channels important in magnesium homeostasis following traumatic brain injury?. Magnesium Research, 22(4), 225-234. DOI Scopus20 WoS14 Europe PMC8 |
| 2009 |
Wheaton, P., Mathias, J., & Vink, R. (2009). Impact of early pharmacological treatment on cognitive and behavioral outcome after traumatic brain injury in adults A meta-analysis. Journal of Clinical Psychopharmacology, 29(5), 468-477. DOI Scopus47 WoS36 Europe PMC37 |
| 2009 |
Vink, R., Cook, N., & Van Den Heuvel, C. (2009). Magnesium in acute and chronic brain injury: an update. Magnesium Research, 22(3), 158S-162S. DOI Scopus43 WoS38 Europe PMC21 |
| 2009 |
Nimmo, A., & Vink, R. (2009). Recent patents in CNS drug discovery: the management of inflammation in the central nervous system.. Recent Patents on CNS Drug Discovery, 4(2), 86-95. DOI Scopus57 Europe PMC49 |
| 2009 |
Kleinig, T., Helps, S., Ghabriel, M., Manavis, J., Leigh, C., Blumbergs, P., & Vink, R. (2009). Hemoglobin crystals: A pro-inflammatory potential confounder of rat experimental intracerebral hemorrhage. Brain Research, 1287, 164-172. DOI Scopus21 WoS17 Europe PMC14 |
| 2009 |
Byard, R., & Vink, R. (2009). The second impact syndrome. Forensic Science, Medicine, and Pathology, 5(1), 36-38. DOI Scopus31 WoS24 Europe PMC20 |
| 2009 |
Donkin, J., Nimmo, A., Cernak, I., Blumbergs, P., & Vink, R. (2009). Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism, 29(8), 1388-1398. DOI Scopus134 WoS114 Europe PMC106 |
| 2009 |
Byard, R., Bhatia, K., Reilly, P., & Vink, R. (2009). How rapidly does cerebral swelling follow trauma? Observations using an animal model and possible implications in infancy. Legal Medicine, 11(SUPPL. 1), 128-131. DOI Scopus24 Europe PMC17 |
| 2009 |
Kleinig, T., & Vink, R. (2009). Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Current Opinion in Neurology, 22(3), 294-301. DOI Scopus117 WoS112 Europe PMC97 |
| 2009 |
Longstreet, D., & Vink, R. (2009). Correlation between total and ionic magnesium concentration in human serum samples is independent of ethnicity or diabetic state. Magnesium Research, 22(1), 32-36. DOI Scopus6 WoS4 Europe PMC2 |
| 2009 |
Cook, N., Vink, R., Donkin, J., & Van Den Heuvel, C. (2009). Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. Journal of Neuroscience Research, 87(1), 34-41. DOI Scopus48 WoS49 Europe PMC44 |
| 2009 |
Vink, R., & Nimmo, A. (2009). Multifunctional Drugs for Head Injury. Neurotherapeutics, 6(1), 28-42. DOI Scopus135 WoS120 Europe PMC106 |
| 2009 |
Newcombe, R., Blumbergs, P., Finnie, J., Reilly, P., Manavis, J., & Vink, R. (2009). Functional and Pathologic studies of experimental chronic compressive spinal cord injury and the effects of decompression. Journal of Neurotrauma, 26(8), 62. |
| 2009 |
Nimmo, A., Donkin, J., Ghabriel, M., & Vink, R. (2009). NK1 tachykinin receptor antagonists prevent altered blood-brain barrier function following trauma. Neuropeptides, 43(5), 442. |
| 2008 |
Longstreet, D., Heath, D., Savage, I., Vink, R., & Panaretto, K. (2008). Estimated nutrient intake of urban Indigenous participants enrolled in a lifestyle intervention program. Nutrition & Dietetics, 65(2), 128-133. DOI Scopus10 WoS9 |
| 2008 |
Vink, R., Bahtia, K., & Reilly, P. (2008). The relationship between intracranial pressure and brain oxygenation following traumatic brain injury in sheep. Acta Neurochirurgica, 102(102), 189-192. DOI Scopus22 WoS19 Europe PMC15 |
| 2008 |
Vink, R., Bahtia, K., & Reilly, P. (2008). The relationship between intracranial pressure and brain oxygenation following traumatic brain injury in sheep. Acta neurochirurgica supplementum, Supplement 102, 189-192. DOI |
| 2007 |
Turner, R., & Vink, R. (2007). Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke. Timely Topics in Medicine. Cardiovascular Diseases, 11, E24. DOI Scopus12 Europe PMC8 |
| 2007 |
O'Connor, C., Cernak, I., Johnson, F., & Vink, R. (2007). Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Experimental Neurology, 205(1), 145-153. DOI Scopus99 WoS90 Europe PMC73 |
| 2007 |
Donkin, J., Turner, R., Hassan, I., & Vink, R. (2007). Substance P in traumatic brain injury. Progress in Brain Research, 161, 97-109. DOI Scopus70 WoS58 Europe PMC54 |
| 2007 |
Van Den Heuvel, C., Thornton, E., & Vink, R. (2007). Traumatic brain injury and Alzheimer's disease: a review. Progress in Brain Research, 161, 303-316. DOI Scopus192 WoS169 Europe PMC139 |
| 2007 |
Longstreet, D., Heath, D., Panaretto, K., & Vink, R. (2007). Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians?. Rural and Remote Health, Online(7), WWW1-WWW13. |
| 2007 |
Turner, R., & Vink, R. (2007). Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke. Drug News & Perspectives, 20(4), 221-226. DOI Scopus18 WoS19 Europe PMC17 |
| 2007 |
Longstreet, D. A., Heath, D. L., Panaretto, K. S., & Vink, R. (2007). Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians.. Rural and Remote Health, 7(4), 843. DOI Scopus17 Europe PMC8 |
| 2006 |
Thornton, E., Vink, R., Blumbergs, P., & Van Den Heuvel, C. (2006). Soluble amyloid precursor protein a reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Research, 1094(1), 38-46. DOI Scopus156 WoS147 Europe PMC132 |
| 2006 |
Wheaton, P., Mathias, J. L., & Vink, R. (2006). Impact of pharmacological treatments on cognitive and behavioural outcome following traumatic brain injury in adults: A meta-analysis. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 58, 232. |
| 2005 |
Longstreet, D., Heath, D., & Vink, R. (2005). A potential link between magnesium intake and diabetes in Indigenous Australians. Medical Journal of Australia, 183(4), 219-220. DOI Scopus4 WoS6 Europe PMC3 |
| 2005 |
O'Connor, C., Cernak, I., & Vink, R. (2005). Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Research, 1062(1-2), 171-174. DOI Scopus147 WoS134 Europe PMC116 |
| 2005 |
Howard, C., Donkin, J., Ghabriel, M., Blumbergs, P., & Vink, R. (2005). A substance P antagonist increases aquaporin-4 expression and reduces oedema after traumatic brain injury. Restorative Neurology and Neuroscience, 23 (3-4), 194. |
| 2004 |
Vink, R. (2004). Meeting report: 10th international magnesium symposium. Magnesium Research, 17(2), 151-153. |
| 2004 |
Turner, R., Van Den Heuvel, C., & Vink, R. (2004). Amiloride increases neuronal damage after traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 534S-537S. DOI Scopus10 WoS11 Europe PMC7 |
| 2004 |
Movesesyan, V., Stoica, B., Yakovlev, A., Knoblach, S., Lea, P., Cernak, I., . . . Faden, A. (2004). Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. Cell Death and Differentiation, 11(10), 1121-1132. DOI Scopus79 WoS68 Europe PMC57 |
| 2004 |
Vink, R., Donkin, J., Cruz, M., Nimmo, A., & Cernak, I. (2004). A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 538S-540S. DOI Scopus33 WoS29 Europe PMC26 |
| 2004 |
Fromm, L., Heath, D., Vink, R., & Nimmo, A. (2004). Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 529S-233S. DOI Scopus79 WoS63 Europe PMC53 |
| 2004 |
Turner, R., Da Silva, K., O'Connor, C., Van Den Heuvel, C., & Vink, R. (2004). Magnesium gluconate offers no more protection than magnesium sulphate following diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 541S-544S. DOI Scopus17 WoS11 Europe PMC6 |
| 2004 |
Van Den Heuvel, C., Donkin, J., Finnie, J., Blumbergs, P., Kuchel, T., Koszyca, B., . . . Vink, R. (2004). Downregulation of amyloid precursor protein (APP) expression following post-traumatic cyclosporin-A administration. Journal of Neurotrauma, 21(11), 1562-1572. DOI Scopus29 WoS27 Europe PMC23 |
| 2004 |
Vink, R., & Van Den Heuvel, C. (2004). Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opinion on Investigational Drugs, 13(10), 1263-1274. DOI Scopus55 WoS50 Europe PMC41 |
| 2004 |
Cernak, I., Vink, R., Zapple, D., Cruz, M., Ahmed, F., Chang, T., . . . Faden, A. (2004). The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiology of Disease, 17(1), 29-43. DOI Scopus146 WoS129 Europe PMC115 |
| 2004 |
Fricke, S., Vink, R., Chiodo, C., Cernak, I., Ileva, L., & Faden, A. (2004). Consistent and reproducible slice selection in rodent brain using a novel stereotaxic device for MRI. Journal of Neuroscience Methods, 136(1), 99-102. DOI Scopus25 WoS24 Europe PMC21 |
| 2004 |
Cernak, I., Vink, R., Natale, J., Stoica, B., Lea, P., Movesesyan, V., . . . Faden, A. (2004). The "dark side" of endocannabinoids: A neurotoxic role for anandamide. Journal of Cerebral Blood Flow and Metabolism, 24(5), 564-578. DOI Scopus54 WoS53 Europe PMC41 |
| 2004 |
Nimmo, A., Cernak, I., Heath, D., Hu, X., Bennett, C., & Vink, R. (2004). Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides, 38(1), 40-47. DOI Scopus129 WoS120 Europe PMC97 |
| 2004 |
Van Den Heuvel, C., & Vink, R. (2004). The role of magnesium in traumatic brain injury. Clinical Calcium, 14(8), 9-14. Scopus39 Europe PMC20 |
| 2003 |
Faden, A., Knoblach, S., Cernak, I., Fan, L., Vink, R., Araldi, G., . . . Kozikowski, A. (2003). Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection In Vitro and In Vivo. Journal of Cerebral Blood Flow and Metabolism, 23(3), 342-354. DOI Scopus71 WoS67 Europe PMC56 |
| 2003 |
Vink, R., Young, A., Bennett, C., Hu, X., O'Connor, C., Cernak, I., & Nimmo, A. (2003). Neuropeptide release influences brain edema formation after diffuse traumatic brain injury. Acta Neurochirurgica. Supplementum, 86(86), 257-260. DOI Scopus67 WoS60 Europe PMC42 |
| 2003 |
O'Connor, C., Heath, D., Cernak, I., Nimmo, A., & Vink, R. (2003). Effects of daily versus weekly testing and pre-training on the assessment of neurologic impairment following diffuse traumatic brain injury in rats. Journal of Neurotrauma, 20(10), 985-993. DOI Scopus34 WoS31 Europe PMC29 |
| 2003 |
Pamphlett, R., Todd, E., Vink, R., McQuilty, R., & Cheema, S. (2003). Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS. Journal of the Neurological Sciences, 216(1), 95-98. DOI Scopus12 WoS13 Europe PMC10 |
| 2003 |
Vink, R., O'Connor, C., Nimmo, A., & Heath, D. (2003). Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats. Neuroscience Letters, 336(1), 41-44. DOI Scopus90 WoS70 Europe PMC55 |
| 2003 |
O'Connor, C., Cernak, I., & Vink, R. (2003). Interaction between anesthesia, gender, and functional outcome task following diffuse traumatic brain injury in rats. Journal of Neurotrauma, 20(6), 533-541. DOI Scopus81 WoS74 Europe PMC70 |
| 2002 |
Vink, R., & Nimmo, A. (2002). Novel therapies in development for the treatment of traumatic brain injury. Expert Opinion on Investigational Drugs, 11(10), 1375-1386. DOI Scopus38 WoS32 Europe PMC25 |
| 2002 |
Cernak, I., OConnor, C., & Vink, R. (2002). Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Experimental Brain Research, 147(2), 193-199. DOI Scopus89 WoS82 Europe PMC67 |
| 2002 |
Cernak, I., Chapman, S., Hamlin, G., & Vink, R. (2002). Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats. Journal of Clinical Neuroscience, 9(5), 565-572. DOI Scopus42 WoS38 Europe PMC33 |
| 2002 |
Nimmo, A., Carstairs, J., Patole, S., Whitehall, J., Davidson, K., & Vink, R. (2002). Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clinical and Experimental Pharmacology and Physiology, 29(8), 661-665. DOI Scopus56 WoS51 Europe PMC38 |
| 2001 |
Vink, R., Nimmo, A., & Cernak, I. (2001). An overview of new and novel pharmacotherapies for use in traumatic brain injury. Clinical and Experimental Pharmacology and Physiology, 28(11), 919-921. DOI Scopus45 WoS42 Europe PMC35 |
| 2001 |
Cernak, I., O'Connor, C., & Vink, R. (2001). Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats. Clinical and Experimental Pharmacology and Physiology, 28(11), 922-925. DOI Scopus60 WoS57 Europe PMC50 |
| 2001 |
Heath, D., & Vink, R. (2001). Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration. Journal of Neurotrauma, 18(4), 465-469. DOI Scopus18 WoS17 Europe PMC14 |
| 2001 |
Russell, M., & Vink, R. (2001). Increased facial temperature as an early warning in Sudden Infant Death Syndrome. Medical Hypotheses, 57(1), 61-63. DOI Scopus13 WoS11 Europe PMC10 |
| 2001 |
Vink, R., Mullins, P., Temple, M., Bao, W., & Faden, A. (2001). Small shifts in craniotomy position in the lateral fluid percussion injury model are associated with differential lesion development. Journal of Neurotrauma, 18(8), 839-847. DOI Scopus75 WoS66 Europe PMC58 |
| 2001 |
Hamlin, G., Cernak, I., Wixey, J., & Vink, R. (2001). Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats. Journal of Neurotrauma, 18(10), 1011-1018. DOI Scopus65 WoS63 Europe PMC53 |
| 2000 |
Alexiou, T., Crane, L. H., & Vink, R. (2000). Increased mortality in female rats after severe diffuse traumatic brain injury is significantly attenuated by magnesium administration. Neuroscience Research Communications, 26(1), 1-8. DOI Scopus3 WoS11 |
| 2000 |
Vink, R., & Cernak, I. (2000). Regulation of intracellular free magnesium in central nervous system injury.. Frontiers in Bioscience A Journal and Virtual Library, 5(1), D656-D665. DOI Scopus76 WoS64 Europe PMC37 |
| 1999 |
Heath, D. L., & Vink, R. (1999). Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. Journal of Pharmacology and Experimental Therapeutics, 288(3), 1311-1316. DOI Scopus86 WoS75 Europe PMC40 |
| 1999 |
Almonte, R. A., Heath, D. L., Whitehall, J., Russell, M. J., Patole, S., & Vink, R. (1999). Gestational magnesium deficiency is deleterious to fetal outcome. Biology of the Neonate, 76(1), 26-32. DOI Scopus44 WoS30 Europe PMC25 |
| 1999 |
Heath, D. L., & Vink, R. (1999). Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats. Journal of Neurosurgery, 90(3), 504-509. DOI Scopus87 WoS80 Europe PMC55 |
| 1999 |
Heath, D. L., & Vink, R. (1999). Brain free magnesium concentration is predictive of motor outcome following traumatic axonal brain injury in rats. Magnesium Research, 12(4), 269-277. Scopus23 WoS24 Europe PMC14 |
| 1999 |
Heath, D. L., & Vink, R. (1999). Concentration of brain free magnesium following severe brain injury correlates with neurologic motor outcome. Journal of Clinical Neuroscience, 6(6), 505-509. DOI Scopus17 WoS15 Europe PMC8 |
| 1999 |
de Sousa, R. M. C. (1999). Traumatic brain injury. REVISTA DE SAUDE PUBLICA, 33(5), 531-532. |
| 1999 |
Heath, D. L., & Vink, R. (1999). Secondary mechanisms in traumatic brain injury: a nurse's perspective.. Journal of Neuroscience Nursing Journal of the American Association of Neuroscience Nurses, 31(2), 97-105. DOI Scopus7 Europe PMC5 |
| 1998 |
Heath, D. L., & Vink, R. (1998). Blood-free magnesium concentration declines following graded experimental traumatic brain injury. Scandinavian Journal of Clinical and Laboratory Investigation, 58(2), 161-166. DOI Scopus29 WoS27 Europe PMC14 |
| 1998 |
Heath, D. L., & Vink, R. (1998). Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: A comparative phosphorus NMR study. Journal of Neurotrauma, 15(3), 183-189. DOI Scopus65 WoS61 Europe PMC41 |
| 1997 |
Vink, R., Golding, E. M., Williams, J. P., & McIntosh, T. K. (1997). Blood glucose concentration does not affect outcome in brain trauma: A 31P MRS study. Journal of Cerebral Blood Flow and Metabolism, 17(1), 50-53. DOI Scopus27 WoS24 Europe PMC21 |
| 1997 |
Heath, D. L., & Vink, R. (1997). Magnesium sulphate improves neurologic outcome following severe closed head injury in rats. Neuroscience Letters, 228(3), 175-178. DOI Scopus39 WoS34 Europe PMC27 |
| 1996 |
Vink, R., Heath, D. L., & McIntosh, T. K. (1996). Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. Journal of Neurochemistry, 66(6), 2477-2483. DOI Scopus66 WoS66 Europe PMC39 |
| 1996 |
Budden, L., & Vink, R. (1996). Paracetamol overdose: pathophysiology and nursing management.. British Journal of Nursing Mark Allen Publishing, 5(3), 145-152. DOI Scopus2 |
| 1996 |
Heath, D. L., & Vink, R. (1996). Brain entracellular free magnesium declines after impact-acceleration induced brain injury in rats. Neuroscience Research Communications, 18(3), 163-168. DOI Scopus5 WoS5 |
| 1996 |
Heath, D. L., & Vink, R. (1996). Traumatic brain axonal injury produces sustained decline in intracellular free magnesium concentration. Brain Research, 738(1), 150-153. DOI Scopus69 WoS61 Europe PMC42 |
| 1995 |
Golding, E. M., & Vink, R. (1995). Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury. Molecular and Chemical Neuropathology, 24(2-3), 137-150. DOI Scopus20 WoS25 Europe PMC14 |
| 1995 |
Mullins, P. G., & Vink, R. (1995). Chronic alcohol exposure decreases brain intracellular free magnesium concentration in rats. Neuroreport, 6(12), 1633-1636. DOI Scopus21 WoS21 Europe PMC9 |
| 1995 |
Yamakami, I., Vink, R., Faden, A. I., Gennarelli, T. A., Lenkinski, R., & McIntosh, T. K. (1995). Effects of acute ethanol intoxication on experimental brain injury in the rat: Neurobehavioral and phosphorus-31 nuclear magnetic resonance spectroscopy studies. Journal of Neurosurgery, 82(5), 813-821. DOI Scopus33 WoS33 Europe PMC23 |
| 1995 |
Headrick, J. P., Faden, A. I., & Vink, R. (1995). Intrathecal dynorphin-A infusion in rat spinal cord causes energy depletion, edema and neurologic dysfunction. Neurochemistry International, 26(5), 489-495. DOI Scopus9 WoS8 Europe PMC9 |
| 1995 |
Heath, D. L., & Vink, R. (1995). Impact Acceleration-Induced Severe Diffuse Axonal Injury in Rats: Characterization of Phosphate Metabolism and Neurologic Outcome. Journal of Neurotrauma, 12(6), 1027-1034. DOI Scopus71 WoS60 Europe PMC50 |
| 1994 |
Headrick, J. P., Bendall, M. R., Faden, A. I., & Vink, R. (1994). Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: Potential role in secondary injury. Journal of Cerebral Blood Flow and Metabolism, 14(5), 853-861. DOI Scopus61 WoS61 Europe PMC52 |
| 1994 |
Hanstock, C. C., Faden, A. I., Bendall, M. R., & Vink, R. (1994). Diffusion-weighted imaging differentiates ischemic tissue from traumatized tissue. Stroke, 25(4), 843-848. DOI Scopus100 WoS91 Europe PMC80 |
| 1994 |
Vink, R., Golding, E. M., & Headrick, J. P. (1994). Bioenergetic Analysis of Oxidative Metabolism Following Traumatic Brain Injury in Rats. Journal of Neurotrauma, 11(3), 265-274. DOI Scopus58 WoS59 Europe PMC42 |
| 1994 |
Golding, E. M., & Vink, R. (1994). Inhibition of phospholipase C with neomycin improves metabolic and neurologic outcome following traumatic brain injury. Brain Research, 668(1-2), 46-53. DOI Scopus14 WoS12 Europe PMC10 |
| 1993 |
Vink, R. (1993). Nuclear magnetic resonance characterization of secondary mechanisms following traumatic brain injury. Molecular and Chemical Neuropathology, 18(3), 279-297. DOI Scopus28 WoS29 Europe PMC20 |
| 1993 |
Emerson, C. S., Headrick, J. P., & Vink, R. (1993). Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females. Brain Research, 608(1), 95-100. DOI Scopus138 WoS131 Europe PMC118 |
| 1992 |
Emerson, C. S., & Vink, R. (1992). Increased mortality in female rats after brain trauma is associated with lower free Mg2+. Neuroreport, 3(11), 957-960. DOI Scopus18 WoS15 Europe PMC8 |
| 1991 |
Vink, R., Portoghese, P. S., & Faden, A. I. (1991). κ-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 261(6 30-6), R1527-R1532. DOI Scopus46 Europe PMC28 |
| 1991 |
Vink, R. (1991). Magnesium and brain trauma.. Magnesium and Trace Elements, 10(1), 1-10. Scopus17 Europe PMC6 |
| 1991 |
VINK, R., PORTOGHESE, P. S., & FADEN, A. I. (1991). KAPPA-OPIOID ANTAGONIST IMPROVES CELLULAR BIOENERGETICS AND RECOVERY AFTER TRAUMATIC BRAIN INJURY. AMERICAN JOURNAL OF PHYSIOLOGY, 261(6), R1527-R1532. DOI WoS44 |
| 1990 |
Vink, R., Head, V. A., Faden, A. I., Rogers, P. J., & Mcintosh, T. K. (1990). Mitochondrial Metabolism Following Traumatic Brain Injury in Rats. Journal of Neurotrauma, 7(1), 21-27. DOI Scopus72 WoS71 Europe PMC63 |
| 1990 |
Vink, R., & McIntosh, T. K. (1990). Pharmacological and physiological effects of magnesium on experimental traumatic brain injury.. Magnesium Research Official Organ of the International Society for the Development of Research on Magnesium, 3(3), 163-169. Scopus47 Europe PMC22 |
| 1990 |
Faden, A. I., Yum, S. W., Lemke, M., & Vink, R. (1990). Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury. Journal of Pharmacology and Experimental Therapeutics, 255(2), 608-614. DOI Scopus33 WoS31 Europe PMC20 |
| 1990 |
Vink, R., McIntosh, T. K., Rhomhanyi, R., & Faden, A. I. (1990). Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats. Journal of Neuroscience, 10(11), 3524-3530. DOI Scopus61 WoS64 Europe PMC43 |
| 1990 |
McIntosh, T. K., Vink, R., Soares, H., Hayes, R., & Simon, R. (1990). Effect of Noncompetitive Blockade of N‐Methyl‐d‐Aspartate Receptors on the Neurochemical Sequelae of Experimental Brain Injury. Journal of Neurochemistry, 55(4), 1170-1179. DOI Scopus154 WoS161 Europe PMC120 |
| 1989 |
McIntosh, T. K., Vink, R., Yamakami, I., & Faden, A. I. (1989). Magnesium protects against neurological deficit after brain injury. Brain Research, 482(2), 252-260. DOI Scopus228 WoS206 Europe PMC159 |
| 1989 |
Mcintosh, T. K., Vink, R., Soares, H., Hayes, R., & Simon, R. (1989). Effects of the N-Methyl-D-Aspartate Receptor Blocker MK-801 on Neurologic Function After Experimental Brain Injury. Journal of Neurotrauma, 6(4), 247-259. DOI Scopus171 WoS167 Europe PMC142 |
| 1989 |
McIntosh, T. K., Vink, R., Noble, L., Yamakami, I., Fernyak, S., Soares, H., & Faden, A. L. (1989). Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion model. Neuroscience, 28(1), 233-244. DOI Scopus1014 WoS988 Europe PMC869 |
| 1989 |
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science, 244(4906), 798-800. DOI Scopus1381 WoS1323 Europe PMC1073 |
| 1989 |
Demediuk, P., Faden, A. I., Romhanyi, R., Vink, R., & McIntosh, T. K. (1989). Changes in lipid metabolism, tissue cations, and water content after fluid-percussion-induced traumatic brain injury in rats.. Journal of Neurotrauma, 6(4), 229. DOI |
| 1989 |
Demediuk, P., Faden, A. I., Romhanyi, R., Vink, R., & McIntosh, T. K. (1989). Letter to the editor. Journal of Neurotrauma, 6(4), 229. DOI |
| 1989 |
Vink, R., Noble, L. J., Knoblach, S. M., Bendall, M. R., & Faden, A. I. (1989). Metabolic changes in rabbit spinal cord after trauma: Magnetic resonance spectroscopy studies. Annals of Neurology, 25(1), 26-31. DOI Scopus32 WoS34 Europe PMC24 |
| 1989 |
DEMEDIUK, P., FADEN, A. I., VINK, R., ROMHANYI, R., & MCINTOSH, T. K. (1989). EFFECTS OF TRAUMATIC BRAIN INJURY ON ARACHIDONIC-ACID METABOLISM AND BRAIN WATER-CONTENT IN THE RAT. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 559, 431-432. WoS4 |
| 1989 |
FADEN, A. I., VINK, R., & McINTOSH, T. K. (1989). Thyrotropin‐Releasing Hormone and Central Nervous System Trauma. Annals of the New York Academy of Sciences, 553(1), 380-384. DOI Scopus32 WoS13 Europe PMC11 |
| 1989 |
Vink, R., Yum, S. W., Lemke, M., Demediuk, P., & Faden, A. I. (1989). Traumatic spinal cord injury in rabbits decreases intracellular free magnesium concentration as measured by 31P MRS. Brain Research, 490(1), 144-147. DOI Scopus23 WoS28 Europe PMC21 |
| 1989 |
Vink, R. (1989). Phospholipase C activity reduces free magnesium concentration. Biochemical and Biophysical Research Communications, 165(2), 913-918. DOI Scopus9 WoS12 Europe PMC5 |
| 1988 |
Vink, R., McIntosh, T. K., & Faden, A. I. (1988). Treatment with the thyrotropin-releasing hormone analog CG3703 restores magnesium homeostasis following traumatic brain injury in rats. Brain Research, 460(1), 184-188. DOI Scopus36 WoS43 Europe PMC20 |
| 1988 |
Vink, R., Faden, A. I., & Mcintosh, T. K. (1988). Changes in Cellular Bioenergetic State Following Graded Traumatic Brain Injury in Rats: Determination by Phosphorus 31 Magnetic Resonance Spectroscopy. Journal of Neurotrauma, 5(4), 315-330. DOI Scopus78 WoS78 Europe PMC69 |
| 1988 |
Mcintosh, T. K., Faden, A. I., Yamakami, I., & Vink, R. (1988). Magnesium Deficiency Exacerbates and Pretreatment Improves Outcome Following Traumatic Brain Injury in Rats: 31P Magnetic Resonance Spectroscopy and Behavioral Studies. Journal of Neurotrauma, 5(1), 17-31. DOI Scopus146 WoS140 Europe PMC98 |
| 1988 |
Demediuk, P., Faden, A. I., Romhanyi, R., Vink, R., & Mcintosh, T. K. (1988). Traumatic Brain Injury in the Rat: Effects on Lipid Metabolism, Tissue Magnesium, and Water Content. Journal of Neurotrauma, 5(2), 105-119. DOI Scopus17 Europe PMC15 |
| 1988 |
McIntosh, T. K., Vink, R., & Faden, A. I. (1988). Beneficial effect of the TRH analog CG-3703 on outcome and survival following traumatic brain injury in rats.. Progress in Clinical and Biological Research, 264, 415-420. Scopus4 Europe PMC1 |
| 1988 |
Vink, R., McIntosh, T. K., Yamakami, I., & Faden, A. I. (1988). 31P NMR characterization of graded traumatic brain injury in rats. Magnetic Resonance in Medicine, 6(1), 37-48. DOI Scopus41 WoS46 Europe PMC39 |
| 1988 |
McIntosh, T. K., Vink, R., & Faden, A. I. (1988). An analogue of thyrotropin-releasing hormone improves outcome after brain injury: 31P-NMR studies. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 254(5), 23/5. DOI Scopus26 WoS32 Europe PMC13 |
| 1988 |
Vink, R., McIntosh, T. K., & Faden, A. I. (1988). Nonedited 1H NMR lactate/n‐acetyl aspartate ratios and the in vivo determination of lactate concentration in brain. Magnetic Resonance in Medicine, 7(1), 95-99. DOI Scopus17 WoS21 Europe PMC14 |
| 1988 |
Vink, R., McIntosh, T. K., Demediuk, P., Weiner, M. W., & Faden, A. I. (1988). Decline in intracellular free Mg2+ is associated with irreversible tissue injury after brain trauma. Journal of Biological Chemistry, 263(2), 757-761. DOI Scopus240 WoS236 Europe PMC164 |
| 1987 |
Vink, R., McIntosh, T. K., Demediuk, P., & Faden, A. I. (1987). Decrease in total and free magnesium concentration following traumatic brain injury in rats. Biochemical and Biophysical Research Communications, 149(2), 594-599. DOI Scopus77 WoS81 Europe PMC52 |
| 1987 |
Mclntosh, T. K., Faden, A. I., Bendall, M. R., & Vink, R. (1987). Traumatic Brain Injury in the Rat: Alterations in Brain Lactate and pH as Characterized by 1H and 31P Nuclear Magnetic Resonance. Journal of Neurochemistry, 49(5), 1530-1540. DOI Scopus107 WoS103 Europe PMC90 |
| 1987 |
Vink, R., Knoblach, S. M., & Faden, A. I. (1987). 31P magnetic resonance spectroscopy of traumatic spinal cord injury. Magnetic Resonance in Medicine, 5(4), 390-394. DOI Scopus24 WoS22 Europe PMC15 |
| 1987 |
VINK, R., McINTOSH, T. K., FERNYAK, S. E., WEINER, M. W., & FADEN, A. I. (1987). Proton and Phosphorus NMR Studies of Traumatic Brain Injury in Rats. Annals of the New York Academy of Sciences, 508(1), 497-500. DOI Scopus2 WoS4 |
| 1987 |
Lemke, M., Demediuk, P., McIntosh, T. K., Vink, R., & Faden, A. I. (1987). Alterations in tissue Mg++, Na+ and spinal cord edema following impact trauma in rats. Biochemical and Biophysical Research Communications, 147(3), 1170-1175. DOI Scopus64 WoS63 Europe PMC54 |
| 1987 |
Vink, R., McIntosh, T. K., Weiner, M. W., & Faden, A. I. (1987). Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study.. Journal of Cerebral Blood Flow and Metabolism Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 7(5), 563-571. DOI Scopus95 WoS106 Europe PMC83 |
| 1985 |
Singh, S. P., Bishop, C. J., Vink, R., & Rogers, P. J. (1985). Regulation of the glucose phosphotransferase system in Brochothrix thermosphacta by membrane energization. Journal of Bacteriology, 164(1), 367-378. DOI Scopus7 WoS11 Europe PMC6 |
| 1984 |
Singh, S. P., Vink, R., & Rogers, P. J. (1984). Regulation of lactate dehydrogenase in Brochothrix thermosphacta. FEMS Microbiology Letters, 22(1), 73-76. DOI Scopus3 WoS5 |
| 1984 |
Vink, R., Bendall, M. R., Simpson, S. J., & Rogers, P. J. (1984). Estimation of H+ to Adenosine 5′-Triphosphate Stoichiometry of Escherichia coli ATP Synthase Using 31P NMR. Biochemistry, 23(16), 3667-3675. DOI Scopus20 WoS25 Europe PMC18 |
| 1983 |
SIMPSON, S. J., BENDALL, M. R., EGAN, A. F., VINK, R., & ROGERS, P. J. (1983). High‐field phosphorus NMR studies of the stoichiometry of the lactate/proton carrier in Streptococcus faecalis. European Journal of Biochemistry, 136(1), 63-69. DOI Scopus23 WoS26 Europe PMC14 |
| 1983 |
Simpson, S. J., Vink, R., Egan, A. F., & Rogers, P. J. (1983). Lactate efflux stimulates [32Pi]ATP exchange in Streptococcus faecalis membrane vesicles. FEMS Microbiology Letters, 19(1), 111-114. DOI Scopus13 WoS18 |
Available For Media Comment.